Oncogenic KrasG12D Activation in the Nonhematopoietic Bone Marrow Microenvironment Causes Myelodysplastic Syndrome in Mice

December 2, 2022 2:58 pm Published by

Osswald L, Hamarsheh S, Uhl FM, Anrieux G, Klein C, Dierks C, Duquesne S, Braun LM, Schmitt-Graeff A, Duyster C, Boerries M, Brummer T and Zeiser R: Oncogenic KrasG12D Activation in the Nonhematopoietic Bone Marrow Microenvironment Causes Myelodysplastic Syndrome in Mice. Mol Cancer Res 19(9):1596-1608 (2021), doi: 10.1158/1541-7786.MCR-20-0275.

Categorised in:

This post was written by redakteur